Non-fibrillar oligomeric species of the amyloid ABri peptide, implicated in familial British dementia, are more potent at inducing apoptotic cell death than protofibrils or mature fibrils

Journal of Molecular Biology

Volumn 310, Issue 1, 2001, Pages 157-168

  El Agnaf, Omar M A ^a   Nagala, Sidhartha ^a   Patel, Bhroma P ^a   Austen, Brian M ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Alzheimer's disease; Amyloid; Familial British dementia; Fibrillogenesis; Neurotoxicity

Indexed keywords

AMINO ACID; AMYLOID; CYCLOPEPTIDE; OLIGOMER; PEPTIDE;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; APOPTOSIS; ARTICLE; AUTOSOMAL DOMINANT DISORDER; BRAIN; CELL DEATH; DEGENERATIVE DISEASE; DEMENTIA; FAMILIAL BRITISH DEMENTIA; FIBER; HUMAN; HUMAN CELL; NEUROTOXICITY; OLIGOMERIZATION; PATHOGENESIS; PATHOLOGY; PEPTIDE SYNTHESIS; POINT MUTATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; STOP CODON;

EID: 0035967889     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.2001.4743     Document Type: Article

References (45)

1. Familial cerebral amyloid angiopathy with nonneuritic plaque formation
2. Atypical Alzheimer's disease with spastic paresis and ataxia
3. Familial cerebral amyloid angiopathy with nonneuritic amyloid plaque formation
4. A stop-codon mutation in the BRI gene associated with familial British dementia
5. Furin mediates enhanced production of fibrillogenic ABri peptides in familial British dementia
6. Evolution of amyloid: What normal protein folding may tell us about fibrillogenesis and disease
7. Glutamine repeats and neuro-degenerative diseases: Molecular aspects
8. Review: Formation and properties of amyloid-like fibrils derived from alpha-synuclein and related proteins
9. Neurotoxicity of a prion protein fragment
10. Neurodegeneration induced by beta-amyloid peptides in vitro: The role of peptide assembly state
11. Aggregates from mutant and wild-type alpha-synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of beta-sheet and amyloid-like filaments
12. Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red
13. Morphology and toxicity of Abeta-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease
14. The toxicity of the Alzheimer's beta-amyloid peptide correlates with a distinct fiber morphology
15. Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate
16. Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates
17. Oligomerization and toxicity of beta-amyloid-42 implicated in Alzheimer's disease
18. Diffusible, nonfibrillar ligands derived from Abetal-42 are potent central nervous system neurotoxins
19. Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons
20. Biological activity associated with a high molecular weight form of β-amyloid
21. Fresh and globular amyloid beta protein (1-42) induces rapid cellular degeneration: Evidence for AβP-channel-mediated cellular toxicity
22. Fractionation and characterization of oligomeric, protofibrillar and fibrillar forms of beta-amyloid peptide
23. Fresh and nonfibrillar amyloid beta protein(1-40) induces rapid cellular degeneration in aged human fibroblasts: Evidence for AβP-channel-mediated cellular toxicity
24. Oligomerization of beta-amyloid of the Alzheimer's and the Dutch-cerebral-haemorrhage types
25. Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: Implications for pathogenesis and therapy
26. Neurological illness in transgenic mice expressing a prion protein with an insertional mutation
27. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions
28. Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models
29. Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain
30. Dopaminergic loss and inclusion body formation in alpha-synuclein mice: Implications for neurodegenerative disorders
31. High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: Synaptotoxicity without plaque formation
32. Effect of the disulophide bridge and the C-terminal extension on the oligomerisation of the amyloid peptide ABri implicated in familial British dementia
33. Selective amyloid staining as a function of amyloid composition and structure. Histochemical analysis of the alkaline Congo red, standardized toluidine blue, and iodine methods
34. Methods for staining amyloid in tissues: A review
35. The congo red stain revisited
36. The intracellular component of cellular 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) reduction is specifically inhibited by beta-amyloid peptides
37. Cytotoxic amyloid peptides inhibit cellular 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) reduction by enhancing MTT formazan exocytosis
38. Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of beta-amyloid-mediated cell death
39. Alternate aggregation pathways of the Alzheimer beta-amyloid peptide: An in vitro model of preamyloid
40. Familial British dementia with amyloid angiopathy: Early clinical, neuropsychological and imaging findings
41. A decamer duplication in the 3′ region of the BRI gene originates an amyloid peptide that is associated with dementia in a Danish kindred
42. Is there a cause-and-effect relationship between alpha-synuclein fibrillization and Parkinson's disease?
43. Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease
44. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse
45. The N-terminal region of non-A beta component of Alzheimer's disease amyloid is responsible for its tendency to assume beta-sheet and aggregate to form fibrils